MERRIMACK PHARMACEUTICALS IN's ticker is and the CUSIP is 590328900. A total of 2 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $24,000 | -80.0% | 19,600 | -49.9% | 0.00% | -100.0% |
| Q1 2017 | $120,000 | +46.3% | 39,100 | +94.5% | 0.00% | 0.0% |
| Q4 2016 | $82,000 | +8100.0% | 20,100 | +20000.0% | 0.00% | – |
| Q3 2016 | $1,000 | -98.1% | 100 | -99.0% | 0.00% | -100.0% |
| Q2 2016 | $52,000 | -94.1% | 9,600 | -90.8% | 0.00% | -91.7% |
| Q1 2016 | $878,000 | +180.5% | 104,900 | +164.9% | 0.01% | +200.0% |
| Q4 2015 | $313,000 | -66.9% | 39,600 | -64.4% | 0.00% | -69.2% |
| Q3 2015 | $947,000 | -33.2% | 111,300 | -3.0% | 0.01% | -35.0% |
| Q2 2015 | $1,418,000 | +35.4% | 114,700 | +30.2% | 0.02% | +25.0% |
| Q1 2015 | $1,047,000 | +82.4% | 88,100 | +73.4% | 0.02% | +77.8% |
| Q4 2014 | $574,000 | -66.8% | 50,800 | -74.2% | 0.01% | -66.7% |
| Q3 2014 | $1,727,000 | -13.8% | 196,700 | -28.4% | 0.03% | -12.9% |
| Q2 2014 | $2,003,000 | +1826.0% | 274,800 | +1234.0% | 0.03% | +1450.0% |
| Q1 2014 | $104,000 | -46.4% | 20,600 | -43.4% | 0.00% | -33.3% |
| Q4 2013 | $194,000 | +506.2% | 36,400 | +338.6% | 0.00% | +200.0% |
| Q3 2013 | $32,000 | -86.4% | 8,300 | -76.2% | 0.00% | -83.3% |
| Q2 2013 | $235,000 | – | 34,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 104,900 | $878,000 | 0.01% |
| SIMPLEX TRADING, LLC | 263 | $13,000 | 0.00% |
| Citadel Advisors | 45,000 | $377,000 | 0.00% |